Cases 21 - 30 of 1,749
AZURITY PHARMACEUTICALS, INC. v. AUROBINDO PHARMA LTD. et al
as 2:2023cv23273
Plaintiff:
AZURITY PHARMACEUTICALS, INC.
Defendant:
AUROBINDO PHARMA LTD. and AUROBINDO PHARMA USA, INC.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
MONTALBANO et al v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv22904
Plaintiff:
ANNETTE MONTALBANO and PATRICK MONTALBANO
Defendant:
JOHN DOES 1-50, AUROBINDO PHARMA, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
WILLIAMS v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv22452
Plaintiff:
BOBBY WILLIAMS
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN, N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
AXSOME MALTA LTD. et al v. ALKEM LABORATORIES LTD. et al
as 2:2023cv20354
Plaintiff:
AXSOME MALTA LTD. and AXSOME THERAPEUTICS, INC.
Defendant:
ALKEM LABORATORIES LTD., AUROBINDO PHARMA USA, INC., HETERO USA INC. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
MCNALL v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv21327
Plaintiff:
MARK MCNALL
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES, LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Allergan USA, Inc., et al. v. MSN Laboratories Private Limited, et al.
as 1:2019cv01727
Counter Defendant:
Allergan USA, Inc., Allergan Holdings Unlimited Company and Eden Biodesign, LLC
Counter Claimant:
MSN Laboratories Private Limited, Alkem Laboratories Limited, Hetero USA Inc. and others
Plaintiff:
Eden Biodesign, LLC.
Defendant:
Sun Pharmaceutical Industries Limited, Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
IVERS v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2023cv21150
Plaintiff:
ANTHONY IVERS
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., ARROW PHARM (MALTA) LTD., TEVA PHARMACEUTICAL INDUSTRIES, LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
BYARS v. Boehringer Ingelheim Corp. et al
as 9:2023cv80063
Plaintiff:
KIMBERLY BYARS
Defendant:
Boehringer Ingelheim Corp., Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim USA Corp. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Louisiana Health Service & Indemnity Company et al v. Celgene Corporation et al
as 1:2023cv07871
Plaintiff:
Louisiana Health Service & Indemnity Company individually and on behalf of all others similarly situated doing business as Blue Cross and Blue Shield of Louisiana and HMO Louisiana, Inc.
Defendant:
Celgene Corporation, Bristol Myers Squibb Company, Aurobindo Pharma Limited and others
Cause Of Action: 15 U.S.C. § 1 Antitrust Litigation (Monopolizing Trade)
Kaplan et al v. GlaxoSmithKline LLC et al
as 3:2023cv17678
Plaintiff:
Kenneth Kaplan and Tamara Kaplan
Defendant:
GlaxoSmithKline LLC, GlaxoSmithKline PLC, GlaxoSmithKline (America) Inc. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
